Lucigen Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Lucigen Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12174
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vectors, and protein expression. It also offers CloneSmart, BigEasy Linear, DNATerminator End Repair Kit, CloneDirect Rapid Ligation Kit, UltraClone DNA Ligation and Transformation Kits, Gel-Ready DNA Ladders, NxGen Exonuclease I, NxGen Lambda Exonuclease and Pyrophosphatase, among others. The company offers next gen sequencing services such as DNA-specific sequencing services and RNA-specific sequencing services. Lucigen is headquartered in Middleton, Wisconsin, the US.

Lucigen Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lucigen Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lucigen Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Lucigen Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lucigen Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Lucigen Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lucigen Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Lucigen Raises USD2.2 Million in Venture Financing 10
Partnerships 11
Lucigen Enters into Distribution Agreement with Illumina 11
SYGNIS Enters into Distribution Agreement with Lucigen 12
Lucigen Enters into Agreement with Thermo Fisher Scientific 13
Lucigen Enters Into Distribution Agreement With Research Corporation Technologies For Endotoxin Free CleanColi Expression System 14
Acquisition 15
LGC Acquires Lucigen 15
Lucigen Corp – Key Competitors 16
Lucigen Corp – Key Employees 17
Lucigen Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
Sep 20, 2017: Patent for the pJAZZ System, useful for cloning challenging DNA, granted to Lucigen 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Lucigen Corp, Medical Equipment, Key Facts 2
Lucigen Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Lucigen Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lucigen Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Lucigen Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lucigen Corp, Deals By Market, 2012 to YTD 2018 8
Lucigen Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lucigen Raises USD2.2 Million in Venture Financing 10
Lucigen Enters into Distribution Agreement with Illumina 11
SYGNIS Enters into Distribution Agreement with Lucigen 12
Lucigen Enters into Agreement with Thermo Fisher Scientific 13
Lucigen Enters Into Distribution Agreement With Research Corporation Technologies For Endotoxin Free CleanColi Expression System 14
LGC Acquires Lucigen 15
Lucigen Corp, Key Competitors 16
Lucigen Corp, Key Employees 17

List of Figures
Lucigen Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Lucigen Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Lucigen Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Lucigen Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Lucigen Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lucigen Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Lucigen Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lucigen Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Lucigen Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Venture Minerals Ltd (VMS):企業の財務・戦略的SWOT分析
    Summary Venture Minerals Ltd (Venture Minerals) is a mining and mineral exploration company. It develops, discovers and explores mineral deposits. The company explores for Copper-Lead-Zinc, Nickel-Cobalt, Nickel-Copper and Nickel-Copper-Cobalt. Its project portfolio includes West Coast Projects, Tas …
  • Toma Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Toma Biosciences Inc (Toma Biosciences) is a biotechnology company that provides genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits developed to detect genomic changes in canc …
  • Aarti Industries Ltd (AARTIIND):企業の財務・戦略的SWOT分析
    Summary Aarti Industries Ltd (Aarti Industries) is a chemical company that manufactures and markets benzene based basic and intermediate chemicals. It offers chemicals, pharma products and surfactants including rubber chemicals, dyes and pigment intermediates; surfactant intermediates, pharmaceutica …
  • A.F. Blakemore & Son Ltd (Foodservice):企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Gunvor Group Limited:石油・ガス:M&Aディール及び事業提携情報
    Summary Gunvor Group Limited (Gunvor) is a vertically integrated energy trading company. It is one of the global traders of physical crude oil; refined products and energy; and metals and bulk materials. The company provides integrated trading products and logistics service to connect upstream suppl …
  • Encompass Health Corp (HLS):製薬・医療:M&Aディール及び事業提携情報
    Summary Encompass Health Corp (Encompass Health), formerly HealthSouth Corp is a post-acute healthcare service provider that offers rehabilitation and home based patient care services. The center owns and operates inpatient rehabilitation and hospitals and provides treatment to medical conditions su …
  • Ceska pojistovna a.s.:企業の戦略的SWOT分析
    Ceska pojistovna a.s. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Genedata AG-製薬・医療分野:企業M&A・提携分析
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Abraxas Petroleum Corp (AXAS):企業の財務・戦略的SWOT分析
    Summary Abraxas Petroleum Corp (Abraxas) operates as an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mid-Continent, Rocky Mountain, Gulf Coast and Permian Basin regions of the US. Abraxas’s Perm …
  • PetroChina Co Ltd (857):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroChina Co Ltd (PetroChina) operates a subsidiary of China National Petroleum Corporation. It is an oil and gas company that explores for and develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical pro …
  • Kepler Weber SA (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber SA (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Churchill Downs Incorporated:企業の戦略・SWOT・財務情報
    Churchill Downs Incorporated - Strategy, SWOT and Corporate Finance Report Summary Churchill Downs Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Novo Nordisk AS (NOVO B):製薬・医療:M&Aディール及び事業提携情報
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Sealed Air Corporation:企業の戦略・SWOT・財務情報
    Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report Summary Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • National Grid USA Service Co Inc:企業の戦略的SWOT分析
    National Grid USA Service Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • LMI Aerospace, Inc.:企業の戦略・SWOT・財務情報
    LMI Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary LMI Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Crispin Speers & Partners Limited:企業の戦略・SWOT・財務情報
    Crispin Speers & Partners Limited - Strategy, SWOT and Corporate Finance Report Summary Crispin Speers & Partners Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Riemser Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatme …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆